Atlas FDA

Solesta Injectable Gel

FDA premarket approval P100014/S024 · decided 2021-05-03

Approval details

PMA number
P100014
Supplement
S024
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Solesta Injectable Gel
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2019-11-21
Decision date
2021-05-03
Days to decision
529 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
Approval to remove heavy metals testing at release of raw materials and final finished product.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26